Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors

Endocrinology

Volumn 144, Issue 6, 2003, Pages 2396-2403

  Rivier, Catherine L ^a   Grigoriadis, Dimitri E ^b   Rivier, Jean E ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; ALCOHOL; ASTRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STRESS; TIME SERIES ANALYSIS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CORTICOTROPIN-RELEASING HORMONE; ELECTROSHOCK; ENDOTOXEMIA; ETHANOL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; PEPTIDE FRAGMENTS; PITUITARY-ADRENAL SYSTEM; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038237647     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-0117     Document Type: Conference Paper

References (75)

1. Vale W, Spiess J, Rivier C, Rivier J 1981 Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin. Science 213:1394-1397
2. Rivier J, Spiess J, Vale W 1983 Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci USA 80:4851-4855
3. Shibahara S, Morimoto Y, Furutani Y, Motake M, Takahashi H, Shimizu S, Horikawa S, Numa S 1983 Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J 2:775-779
4. Rivier C, Plotsky PM 1986 Mediation by corticotropin-releasing factor (CRF) of adenohypophysial hormone secretion. In: Berne RM, ed. Annual review of physiology. Palo Alto, CA: Academic Press; 475-494
5. Irwin M, Vale W, Rivier C 1990 Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity. Endocrinology 126:2837-2844
6. Rivest S, Rivier C 1995 The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocr Rev 16:177-199
7. Taché Y, Mönnikes H, Bonaz B, Rivier J 1993 Role of CRF in stress-related alterations of gastric and colonic motor function. In: Taché Y, Rivier C, eds. Corticotropin-releasing factor and cytokines: role in the stress response. New York: The New York Academy of Sciences; 233-243
8. Heinrichs SC, Richard D 1999 The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 33:350-359
9. Fisher LA, Brown MR 1983 Corticotropin-releasing factor: central nervous system effects on the sympathetic nervous system and cardiovascular regulation. In: Ganten D, Pfaff D, eds. Current topics in neuroendocrinology. Heidelberg: Springer-Verlag; 87-101
10. Brown MR 1991 Brain peptide regulation of autonomic nervous and neuroendocrine functions. In: Brown MR, Koob GF, Rivier C, eds. Stress: neurobiology and neuroendocrinology. New York: Marcel Decker; 193-216.
11. Menzaghi F, Rassnick S, Heinrichs S, Baldwin H, Pich E, Weiss F, Koob G 1994 The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann NY Acad Sci 739:176-184
12. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, Britton KT 1993 The role of corticotropin-releasing factor in behavioural responses to stress. London: Ciba Foundation Symposium No. 172 on Corticotropin-Releasing Factor; 277-295
13. Takahashi LK 2001 Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci Biobehav Rev 25:627-636
14. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, Smith M 1993 Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14:303-347
15. Chen R, Lewis K, Perrin M, Vale W 1993 Expression cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci USA 90:8967-8971
16. Chang C-P, Pearse R, O'Conell S, Rosenfeld G 1993 Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11:1187-1195
17. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW 1993 Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133:3058-3061
18. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikian L, Sawchenko P, Vale W 1995 Identification of a second corticotropin-releasing factor receptor gene and charancterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92:2969-2973
19. Kishimoto T, Pearse R, Lin C, Rosenfeld M 1995 A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92:1108-1111
20. Vita N, Laurent P, Lefort S, Chalon P, Lelias J-M, Kaghad M, Le Fur G, Caput D, Ferrara P 1993 Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335:1-5
21. Lovenberg T, Liaw C, Grigoriadis D, Clevenger W, Chalmers D, Souza ED, Oltersdorf T 1995 Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840
22. Li H-Y, Ericsson A, Sawchenko PE 1996 Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA 93:2359-2364
23. Sawchenko P 2000 Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. In: Mayer E, Saper C, eds. Progress in brain research. New York: Elsevier Sciences; 61-78
24. Rivier C 1996 Alcohol stimulates ACTH secretion in the rat: mechanisms of action and interactions with other stimuli. Alcohol Clin Exp Res 20:240-254
25. Perrin M, Vale W, Corticotropin releasing factor receptors. In: Pangalos MN, Davies CH, eds. Structure and function of GPCRs in the nervous system. Oxford: Oxford University Press, in press
26. Smith GW, Aubry J-M, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee K-F 1998 Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102
27. Preil J, Muller MB, Gesing A, Reul JM, Sillaber I, van Gaalen MM, Landgrebe J, Holsboer F, Stenzel-Poore M, Wurst W 2001 Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology 142:4946-4955
28. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee K-F 2000 Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410-414
29. Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee KF 2002 Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 22:193-199
30. Turnbull A, Smith G, Lee S, Vale W, Lee K-F, Rivier C 1999 CRF type 1 receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology 140:1013-1017
31. Rivier C 2001 Does IL-6 release ACTH by exerting a direct influence in the rat anterior pituitary? Stress 4:39-55
32. Rivier C 1999 Gender, sex steroids, corticotropin-releasing factor, nitric oxide and the HPA response to stress. Pharmacol Biochem Behav 64:739-751
33. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Tache Y, Vale W 2002 Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45:4737-4747
34. Rivier J, Gulyas J, Corrigan A, Martinez V, Craig A, Taché Y, Vale W, Rivier C 1998 Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat. J Med Chem 41:5012-5019
35. Rivier J, Kirby D, Lahrichi S, Corrigan A, Vale W, Rivier C 1999 Constrained corticotropin releasing factor antagonists (Astressin analogues) with long-duration of action in the rat. J Med Chem 42:3175-3182
36. Heinrichs S, Souza Ed, Schulteis G, Lapsansky J, Grigoriadis D 2002 Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type 1 receptor selective antagonist. Neuropsychopharmacology 27:194-202
37. Ogilvie K, Rivier C 1997 Effect of three different modes of alcohol administration on the activity of the rat hypothalamic-pituitary-adrenal axis. Alcohol Clin Exp Res 21:467-476
38. Kim C, Rivier C 2000 Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. Endocrinology 141:2244-2253
39. Wilcoxen K, Chen C, Cha M, Haddach M, Bozigian H, McCarthy J, Souza Ed, Grigoriadis D, Discovery of orraly active 3-(3-pyridyl)pyrazol[1,5-a]pyrimidines as nonpeptide CRF1 receptor antagonists. Proceedings of the 30th Annual Meeting of the Society for Neuroscience, New Orleans, LA, 2002, III:4-9 (Abstract 807.3)
40. Turnbull AVT, Rivier CL 1999 Regulation of the hypothalamo-pituitary-adrenal (HPA) axis by cytokines: actions and mechanisms of action. Physiol Rev 79:1-71
41. Rivier C, Shen G 1994 In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1β, vasopressin and oxytocin. J Neurosci 14:1985-1993
42. Rivier C 1999 Effect of acute alcohol treatment on the release of ACTH, corticosterone and pro-inflammatory cytokines in response to endotoxin. Alcohol Clin Exp Res 23:673-682
43. Rivier C 1995 Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Front Neuroendocrinol 16:151-182
44. Coste SC, Murray SE, Stenzel-Poore MP 2001 Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 22:733-741
45. Gully D, Geslin M, Serva L, Fontaine E, Roger P, Lair C, Darre V, Marcy C, Rouby PE, Simiand J, Guitard J, Gout G, Steinberg R, Rodier D, Griebel G, Soubrie P, Pascal M, Pruss R, Scatton B, Maffrand JP, Le Fur G 2002 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2- cyclopropyl-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N- (2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization. J Pharmacol Exper Ther 301:322-332
46. Turnbull AV, Rivier C 1996 Cytokines within the neuroendocrine system. Curr Opin Endocrinol Diab 3:149-156
47. Rivier C, Rivest S, Mechanisms mediating the effects of cytokines of neuroendocrine functions in the rat. Ciba Foundation Symposium, London, UK, 1992, pp 204-225
48. Rivier C 1993 Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat. Ann NY Acad Sci 796:97-105.
49. Rivier C, Vale W 1983 Interaction of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on ACTH secretion in vivo. Endocrinology 113:939-942
50. Rivier C, Vale W 1983 Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305:325-327
51. Rivier C 1994 Endogenous nitric oxide participates in the activation of the hypothalamic-pituitary-adrenal axis by noxious stimuli. Endocr J 2:367-373
52. Bugajski J, Olowska A, Gadek-Michalska A, Borycz J, Glod R, Bugajski A 1996 Effect of indomethacin on the CRH- and VP-induced pituitary-adrenocortical response during social stress. Life Sci 58:PL-67-PL-72
53. Rivier C, Rivier J, Lee S 1996 Importance of pituitary and brain receptors for corticotropin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Brain Res 721:83-90
54. Van Pett K, Viau V, Bittencourt JC, Chan RKW, Li H-Y, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE 2000 Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212
55. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP 2000 Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24:403-409
56. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136:4139-4142
57. Makino S, Gold PW, Schulkin J 1994 Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640:105-112
58. Lacroix S, Rivest S 1996 Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain. J Chem Neuroanat 10:53-71
59. Lee S, Rivier C 1997 Alcohol increases the expression of type 1, but not type 2α corticotropin-releasing factor (CRF) receptor messenger ribonucleic acid in the rat hypothalamus. Mol Brain Res 52:78-89
60. Drolet G, Rivest S 2001 Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo. Peptides 22:761-767
61. Bittencourt JC, Sawchenko PE 2000 Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J Neurosci 20:1142-1156
62. 2) in hypothalamus and amygdala of the immature rat by sensory input and food intake. J Neurosci 19:3982-3991
63. Roland B, Sawchenko P 1993 Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol 332:123-143
64. Levine S 2001 Primary social relationships influence the development of the hypothalamic-pituitary-adrenal axis in the rat. Physiol Behav 73:255-260
65. Meaney MJ 2001 Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 24:1161-1192
66. Liu D, Caldji C, Sharma S, Plotsky PM, Meaney MJ 2000 Influence of neonatal rearing conditions on stress-induced adrenocorticotropin responses and norepinepherine release in the hypothalamic paraventricular nucleus. J Neuroendocrinol 12:5-12
67. Welberg LAM, Seckl JR 2001 Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 13:113-128
68. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, Chrousos G 1997 Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139:403-413
69. Karalis K, Muglia LJ, Bae D, Hilderbrand H, Majzoub JA 1997 CRH and the immune system. J Neuroimmunol 72:131-136
70. Karalis KP, Kontopoulos E, Muglia LJ, Majzoub JA 1999 Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine. Proc Natl Acad Sci USA 96:7093-7097
71. Venihaki M, Dikkes P, Carrigan A, Karalis KP 2001 Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 108:1159-1166
72. Veraksits A, Bileviciute-Ljungar I, Maaroos J, Vasar E, Lundeberg T 2000 Neuronal mechanisms contribute to corticotropin-releasing factor-induced anti-oedema effect in the rat hind paw. Neuropeptides 34:129-134
73. Rivier C 2001 The hypothalamic-pituitary-adrenal axis response to immune signals. In: Felten D, ed. Psychoneuroimmunology. 3rd ed. Palo Alto, CA: Academic Press; 633-648
74. Webster EL, Barrientos RM, Contoreggi C, Isaac MG, Ligier S, Gabry KE, Chrousos GP, McCarthy EF, Rice KC, Gold PW, Sternberg EM 2002 Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J Rheumatol 29:1252-1261
75. Agelaki S, Tsatsanis C, Gravanis A, Margioris AN 2002 Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun 70:6068-6074